A meta-analysis involving 9764 NSCLC patients [49] showed that the incidence of EGFR mutation was significantly higher in patients with TTF-1 overexpression than that in TTF-1 negative patients (OR = 5.19). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.